Cargando…

A novel monoclonal antibody KMP1 has potential antitumor activity of bladder cancer by blocking CD44 in vivo and in vitro

Bladder cancer becomes a serious medical and social concern due to its high recurrence and mortality rates. Thus, it is urgent to search a novel prognostic biomarker and targeted therapy with high sensitivity and specificity. In this study, we used the human bladder cancer cell line EJ as an immunog...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yujin, Wang, Haifeng, Zuo, Yigang, Li, Ning, Ding, Mingxia, Li, Chong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943472/
https://www.ncbi.nlm.nih.gov/pubmed/29577645
http://dx.doi.org/10.1002/cam4.1446